These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26346519)

  • 1. Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations.
    Kanamori K; Aoyagi T; Mikamo T; Tsutsui K; Kunishima T; Inaba H; Hayami N; Murakawa Y
    Int Heart J; 2015; 56(5):555-7. PubMed ID: 26346519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.
    Miwa Y; Ikeda T; Mera H; Miyakoshi M; Hoshida K; Yanagisawa R; Ishiguro H; Tsukada T; Abe A; Yusu S; Yoshino H
    Circ J; 2010 May; 74(5):856-63. PubMed ID: 20339194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].
    Shimomura T; Fujii G; Suzuki S; Miyahara K; Matsuura A; Yoshida K; Kasamatsu M
    Kyobu Geka; 2004 Mar; 57(3):229-32. PubMed ID: 15035081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
    Park H; Otani H; Noda T; Sato D; Okazaki T; Ueyama T; Iwasaka J; Yamamoto Y; Iwasaka T
    Int J Cardiol; 2013 Aug; 167(4):1547-51. PubMed ID: 22608892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal dose of landiolol for preventing abrupt changes in both cardiac output and middle cerebral artery flow velocity after electroconvulsive therapy.
    Kadoi Y; Saito S
    J ECT; 2014 Sep; 30(3):224-6. PubMed ID: 24755725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs.
    Park H; Otani H; Oishi C; Fujikawa M; Yamashita K; Okazaki T; Sato D; Ueyama T; Iwasaka J; Yamamoto Y; Iwasaka T
    Int J Cardiol; 2011 Feb; 146(3):347-53. PubMed ID: 19709770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative use of a beta blocker in coronary artery bypass grafting.
    Ogawa S; Okawa Y; Goto Y; Aoki M; Baba H
    Asian Cardiovasc Thorac Ann; 2013 Jun; 21(3):265-9. PubMed ID: 24570490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
    Harasawa R; Hayashi Y; Iwasaki M; Kamibayashi T; Mashimo T
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):793-5. PubMed ID: 17138082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study].
    Ohsuda M; Edanaga M; Mimura M; Nakayama Y; Kirita A; Koro S; Yamaya K; Kurihara M; Yamakage M
    Masui; 2012 Feb; 61(2):159-63. PubMed ID: 22413438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of landiolol hydrochloride after off-pump coronary artery bypass.
    Maisawa K; Yamazaki K; Ishitoya H; Shimamura Y
    Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):170-5. PubMed ID: 24532615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan.
    Igarashi A; Fujito K; Hirano M; Fukuda T
    J Med Econ; 2014 Feb; 17(2):142-7. PubMed ID: 24351028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Hanada K; Higuma T; Nishizaki F; Sukekawa T; Yokota T; Yamada M; Saito S; Kushibiki M; Oikawa K; Abe N; Tomita H; Osanai T; Okumura K
    Circ J; 2012; 76(2):439-45. PubMed ID: 22156314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful anesthetic management of a patient with thyroid storm using landiolol].
    Fukushima T; Tokioka H; Ishii F; Mikane T; Oku S; Fujii H; Katayama D; Kawanishi S; Kosaka J; Nagano Y
    Masui; 2007 Feb; 56(2):193-5. PubMed ID: 17315739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, open-label study of an intravenous short-acting β1-adrenergic receptor antagonist landiolol hydrochloride for coronary computed tomography angiography by 16-slice multi-detector computed tomography in Japanese patients with suspected ischemic cardiac disease.
    Hirano M; Yamashina A; Hara K; Ikari Y; Jinzaki M; Iino M; Yamaguchi T; Tanimoto M; Kuribayashi S;
    Drugs R D; 2014 Sep; 14(3):185-94. PubMed ID: 25091378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme electrical storm in a patient with an implantable cardioverter defibrillator.
    Sela R; Gellerman M; Kalfon E; Atar S
    Isr Med Assoc J; 2014 Aug; 16(8):513-5. PubMed ID: 25269346
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perioperative and postoperative management of two patients with uncontrolled hyperthyroidism using short acting beta blocker, landiolol].
    Fujita Y; Shimizu T; Matsumoto A; Aoki M
    Masui; 2008 Sep; 57(9):1143-6. PubMed ID: 18807903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
    Kobayashi S; Murakami W; Myoren T; Tateishi H; Okuda S; Doi M; Nao T; Wada Y; Matsuzaki M; Yano M
    Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
    Hoshi T; Sato A; Nishina H; Kakefuda Y; Wang Z; Noguchi Y; Aonuma K
    J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous administration of landiolol reduced QT dispersion in postoperative patients.
    Suzuki K; Numaguchi A; Adachi YU; Obata Y; Hatano T; Ejima T; Sato S; Matsuda N
    J Clin Anesth; 2014 Sep; 26(6):438-42. PubMed ID: 25204509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.